Assessment of sleep-disordered breathing using a non-contact bio-motion sensor.

Obstructive sleep apnoea is a highly prevalent but under-diagnosed disorder. The gold standard for diagnosis of obstructive sleep apnoea is inpatient polysomnography. This is resource intensive and inconvenient for the patient, and the development of ambulatory diagnostic modalities has been identified as a key research priority. SleepMinder (BiancaMed, NovaUCD, Ireland) is a novel, non-contact, bedside sensor, which uses radio-waves to measure respiration and movement. Previous studies have shown it to be effective in measuring sleep and respiration. We sought to assess its utility in the diagnosis of obstructive sleep apnoea. SleepMinder and polysomnographic assessment of sleep-disordered breathing were performed simultaneously on consecutive subjects recruited prospectively from our sleep clinic. We assessed the diagnostic accuracy of SleepMinder in identifying obstructive sleep apnoea, and how SleepMinder assessment of the apnoea-hypopnoea index correlated with polysomnography. Seventy-four subjects were recruited. The apnoea-hypopnoea index as measured by SleepMinder correlated strongly with polysomnographic measurement (r = 0.90; P ≤ 0.0001). When a diagnostic threshold of moderate-severe (apnoea-hypopnoea index ≥15 events h(-1) ) obstructive sleep apnoea was used, SleepMinder displayed a sensitivity of 90%, a specificity of 92% and an accuracy of 91% in the diagnosis of sleep-disordered breathing. The area under the curve for the receiver operator characteristic was 0.97. SleepMinder correctly classified obstructive sleep apnoea severity in the majority of cases, with only one case different from equivalent polysomnography by more than one diagnostic class. We conclude that in an unselected clinical population undergoing investigation for suspected obstructive sleep apnoea, SleepMinder measurement of sleep-disordered breathing correlates significantly with polysomnography.

A portable automated assessment tool for sleep apnea using a combined Holter-oximeter.

STUDY OBJECTIVES: Resource limitations have raised interest in portable monitoring systems that can be used by specialist sleep physicians as part of an overall strategy to improve access to the diagnosis of sleep apnea. This study validates a combined electrocardiogram and oximetry recorder (Holter-oximeter) against simultaneous polysomnography for detection of sleep apnea. DESIGN: Prospective study. SETTING: A dedicated sleep disorders unit. PARTICIPANTS: 59 adults presenting for evaluation of suspected sleep apnea. INTERVENTIONS: NA. MEASUREMENTS AND RESULTS: An automated algorithm previously developed for sleep apnea detection was applied to the electrocardiogram and oximetry measurements. The algorithm provides (a) epoch-by-epoch estimates of apnea occurrence and (b) estimates of overall per-subject AHI. Using separate thresholds of AHI > or =15 and AHI <5 for defining clinically significant and insignificant sleep apnea, sensitivity, specificity, and likelihood ratios, conditional on positive or negative (but not indeterminate) test results were used to assess agreement between the proposed system and polysomnography. Sensitivity of 95.8% and specificity of 100% was achieved. Positive and negative likelihood ratios were >20 and 0.04 respectively, with 16.7% of subjects having intermediate test results (AHI 5-14/h). Regardless ofAHI, 85.3% of respiratory events were correctly annotated on an epoch-by-epoch basis. AHI underestimation bias was 0.9/h, and the antilogs of log-transformed limits of agreement were 0.3 and 2.7. Correlation between estimated and reference AHI was 0.95 (P <0.001). CONCLUSION: Combined Holter-oximeter monitoring compares well with polysomnography for identifying sleep apnea in an attended setting and is potentially suitable for home-based automated assessment of sleep apnea in a population suspected of having sleep apnea.

Assessment of sleep/wake patterns using a non-contact biomotion sensor.

We evaluate a contact-less continuous measuring system measuring respiration and activity patterns system for identifying sleep/wake patterns in adult humans. The system is based on the use of a novel non-contact biomotion sensor, and an automated signal analysis and classification system. The sleep/wake detection algorithm combines information from respiratory frequency, magnitude, and movement to assign 30 s epochs to either wake or sleep. Comparison to a standard polysomnogram system utilizing manual sleep stage classification indicates excellent results. It has been validated on overnight studies from 12 subjects. Wake state was correctly identified 69% and sleep with 88%. Due to its ease-of-use and good performance, the device is an excellent tool for long term monitoring of sleep patterns in the home environment in an ultraconvenient fashion.

Telephony-based voice pathology assessment using automated speech analysis.

A system for remotely detecting vocal fold pathologies using telephone-quality speech is presented. The system uses a linear classifier, processing measurements of pitch perturbation, amplitude perturbation and harmonic-to-noise ratio derived from digitized speech recordings. Voice recordings from the Disordered Voice Database Model 4337 system were used to develop and validate the system. Results show that while a sustained phonation, recorded in a controlled environment, can be classified as normal or pathologic with accuracy of 89.1%, telephone-quality speech can be classified as normal or pathologic with an accuracy of 74.2%, using the same scheme. Amplitude perturbation features prove most robust for telephone-quality speech. The pathologic recordings were then subcategorized into four groups, comprising normal, neuromuscular pathologic, physical pathologic and mixed (neuromuscular with physical) pathologic. A separate classifier was developed for classifying the normal group from each pathologic subcategory. Results show that neuromuscular disorders could be detected remotely with an accuracy of 87%, physical abnormalities with an accuracy of 78% and mixed pathology voice with an accuracy of 61%. This study highlights the real possibility for remote detection and diagnosis of voice pathology.

Non-episode-dependent assessment of paroxysmal atrial fibrillation through measurement of RR interval dynamics and atrial premature contractions.

A method is presented for classifying a single lead surface electrocardiogram recording from a Holter monitor as being from a subject with paroxysmal atrial fibrillation (PAF) or not. The technique is based on first assessing the likelihood of 30-min segments of electrocardiogram (ECG) being from a subject with PAF, and then combining these per-segment likelihoods to form a per-subject classification. The per-segment assessment is based on the output of a supervised linear discriminant classifier (LDC) which has been trained using known data from the Physionet Atrial Fibrillation Prediction Database (which consists of two hundred 30-min segments of Holter ECG, taken from 53 subjects with PAF, and 47 without). One of two LDCs is used depending on whether there is a significant correlation between observed low-frequency and high-frequency spectral power in the RR power spectral density over the 30-min segment. If there is high correlation, then the LDC uses spectral features calculated over a 10-min window; in the low-correlation case, both spectral features and atrial premature contractions are used as features. The classifier was tested for its ability to distinguish PAF and non-PAF segments using three independent data sets (representing a total of 1370 segments from 50 subjects). The cumulative sensitivity, specificity, and accuracy on a per-segment basis were 43.0, 99.3, and 80.5%, respectively on these independent test sets. By combining the results of segment classification, a per-subject classification into PAF and non-PAF classes was performed. For the 50 subjects in the independent data sets, the sensitivity and specificity of the per-subject classifier were 100%.